cancer

The results could have implications for treating cancer, when people’s blood-forming stem cells may be depleted, and for people undergoing transplant surgery.

The state-funded IMPACT program provides access to free treatment for uninsured and underinsured men in California.

The precision-based medicine approach will allow people with newly diagnosed leukemia to have immediate access to new treatments that are in development.

A new mindfulness workshop called Tree of Life Fulfillment offered at the Simms/Mann-UCLA Center for Integrative Oncology combines art therapy with guided imagery.

UCLA Health joins a campaign to promote sun safety with dozens of sunscreen dispenser kiosks at Los Angeles-area beaches.

The availability of such cells — with properties similar to those from humans and other animals — should help scientists accelerate research on therapies for cancer and autoimmune diseases.

The findings help explain the connection between HDL cholesterol and reduced cancer risk, and suggest that a similar compound may be an effective therapy in humans.

Nearly 30 percent of people in the ongoing trial have survived for at least three years after they enrolled in the study; the average life expectancy for people with glioblastoma is 15 to 17 months.

Understanding colon cancer's ability to change its genes — a process called immunoediting — could help researchers develop new immunotherapies that target those genetic changes, leading to more effective treatments.

The next step is to determine why the numbers are so low and find ways to increase those rates of testing.

In a prior study, the same researchers showed that pathologists disagreed about the diagnosis of early-stage invasive melanoma more than 50 percent of the time.

Researchers have found that two targeted therapies could be more effective if used in combination to treat squamous cell carcinomas of the lung.

The cells that de-differentiated — meaning that they reverted back to a less-mature cell — showed sensitivity to a type of self-inflicted cell death called ferroptosis.

UCLA Anderson’s Elisa Long, informed by personal experience, parses data to help those mulling mastectomy and gynecological surgeries to reduce cancer risk.

Three fact sheets recommend that legislators enact changes to help patients and survivors — particularly low-income women — who face serious obstacles to care.

UCLA chemistry professor helped develop Erleada, which was recently approved by the FDA for treating an especially lethal form of prostate cancer.

The research is the first of its kind to compare results between radiotherapy treatments that are higher than the standard dose and traditional treatments, such as radiation and prostatectomy.

UCLA researchers discovered that these patients had a number of unmet psychological and health information needs, particularly during the first three months after their diagnoses.

The advance shows great promise for helping the body’s immune system seek out and destroy cancer cells.

UCLA researcher Steven Mittelman’s work could change not just how doctors treat leukemia, but how they treat other cancers that are also fed by fat.

Chimeric antigen receptor T cell therapy fights disease by bolstering the body’s own natural defenses. Josh Feldman, diagnosed with lymphoma after returning from his honeymoon, knows the difference it can make.

The techniques the researchers employed should pave the way to additional studies on the tumors’ molecular details.

Boosting cholesterol levels in mice spurs their intestinal stem cells to divide faster, dramatically speeding the formation of tumors.

There is no drug or vaccine to treat or prevent KSHV, which causes cancer, but the researchers showed that an inhibitor could be developed to break it down.

Blood and platelet donations sustained 2-year-old as she fought two rare cancers at UCLA Mattel Children’s Hospital.